21 January 2021

Key insights

US – There is likely to be a boom in healthcare spending and investment in 2021, according to health industry figures. Investment in pharma, medtech and digital health is expected to reach new heights. The trigger for increased spending is the huge personal savings that have accumulated during COVID-19 related shutdowns.

Canada – Borders remain closed. Essential travel for Canadian and US citizens is permitted, and this includes trade shipments via rail and truck, people carrying out essential work, immediate family, students and those needing to travel on compassionate grounds. Exempt travelers must still self-quarantine for 14 days. Australians are allowed to transit through the US from Canada if they have a valid airline ticket to Australia.

Market opportunities

Food & Agri

US There is a move to provide virtual re-marking trade services for Australian meat exporters. This service is required when the United States Department of Agriculture refuses product entry owing to missing, incorrect, or incomplete shipping marks. Virtual re-marking provides a significant cost savings to Australian meat producers. Austrade is currently waiving services fees for this service until December 31.


Canada Australia is seen as having a strong competitive advantage for the roll out of drone-based services, because of our regulatory environment. A Canadian company recently tested its drone systems by using them to deliver masks and sanitiser to remote indigenous communities in Canada. A number of companies are looking at potential pilot projects in Australia to prove commercial viability.

US The Undersecretary of Defense for Acquisition and Sustainment, Ellen Lord, announced that the US DoD is using industry feedback to draft new guidance to streamline the process of providing financial reimbursements to contractors impacted by the pandemic. Australian-owned US-registered companies may be able to make claims under Section 3610 of the CARES Act of March 2020.


US Increased demand in the logistics industry and real estate sector has triggered opportunities for Australian companies with innovative logistics solutions and retailtech.


Canada – To stimulate the economy, the province of Ontario is investing in major infrastructure projects – including in transit systems, highways and broadband. C$37 million of that investment is being allocated to training 15,000 students to obtain skills in supporting industries, such as advanced manufacturing. Australian VET organisations interested in this opportunity should contact Austrade for more details.

Health & medtech

US According to EY’s chief economist, US consumers have $2 trillion more saved than would have been the case without the various COVID-19-related shutdowns. These savings are expected to lead to a strong comeback in demand for health services in the second half of 2021.

US Life science deals are expected to bounce back quickly. One bright spot throughout 2020 has been biotech IPOs coming online in record-breaking numbers. However, with more companies listing sooner, it is challenging pharma corporate investors to look at increasingly earlier company stages for deal flow. Companies seeking corporate partners should be prepared to produce strong data and a clear market plan.

US – Clinical trials research has slowed and there is an 18-month backlog in viral vector manufacturing for gene therapies. Australia’s ability to quickly restart clinical trials would offer a significant opportunity to secure more clinical trial projects from the US.

US – Boston-based Novellus is developing a cell-therapy treatment for acute respiratory failure and is looking to find connections, run trials and develop partners in the Australian market. Australia’s proven ability to partner in high quality research at a low relative cost is attractive to US pharma companies. The US Health Team believes US demand for these services will remain strong.

US – The digital health market was increasing by 10–15% per year prior to the pandemic, and this rate will now accelerate. Two major trends driving this acceleration are an increase in virtual services and a decline in in-person and elective procedures. Opportunities for Australian companies include telehealth and remote monitoring, patient engagement, clinical trial technologies, and pharmacy benefits technologies. Companies looking for growth opportunities in the US in these areas should contact the Austrade centre for more information.

US – There is growing interest in finding opportunities to use artificial intelligence to improve drug discovery and repurposing – including for personalised medicine. Industry leaders have noted that an absence of regulation in this areas is inhibiting investment. This may provide opportunities for Australian expertise.


Be the first to try the next generation of Australian export services

Find export markets - BETA

Know which market has the most potential for your business? You may be surprised which is best for you. Find out now!

Go to find export markets

Export market profiles - BETA

Access insights about your industry’s trending export markets. Take the next step and expand your business overseas.

Go to export market profiles

e-commerce insights

Get market insights in recorded webinars by Austrade and industry practitioners and learn how COVID-19 has impacted cross border e-commerce.

Go to e-commerce page